Clinical Trials Browser

Carcinoma, Hepatocellular

HER2-positive Breast Cancer

Carcinoma, Hepatocellular

Fibrolamellar hepatocellular carcinoma, Carcinoma, Hepatocellular, Neoplasms

Lymphoma, Non-Hodgkin, Multiple Myeloma, Neoplasms

Prostatic Neoplasms

Carcinoma, Non-Small-Cell Lung

Prostatic Neoplasms

Triple Negative Breast Neoplasms

Lung Neoplasms

Squamous Cell Carcinoma of Head and Neck, Carcinoma, Squamous Cell

Carcinoma, Non-Small-Cell Lung, Genomic Instability

Breast Neoplasms, Neoplasm, Residual, Triple Negative Breast Neoplasms

Carcinoma, Hepatocellular

Urinary Bladder Neoplasms, Carcinoma, Renal Cell, Lung Neoplasms

HER2-positive Metastatic Breast Cancer

Lung Neoplasms

Head and Neck Neoplasms

Neoplasms, Gastrointestinal Stromal Tumors

Carcinoma, Hepatocellular

Lung Neoplasms, Small Cell Lung Carcinoma

Carcinoma, Hepatocellular

Small Cell Lung Carcinoma

Breast Neoplasms

Carcinoma, Uterine Cervical Neoplasms

NSCLC Stage IIIB~IV

Breast Neoplasms

Glioblastoma

Carcinoma, Hepatocellular, Cholangiocarcinoma

Adenoviridae Infections, Glioblastoma

Osteosarcoma

Rhabdomyosarcoma

Brain Neoplasms, Melanoma

Lung Neoplasms, Carcinoma, Neuroendocrine

Advanced Solid Malignancies

Small Cell Lung Carcinoma

Endometrial Neoplasms

Carcinoma, Hepatocellular

Lung Neoplasms, Small Cell Lung Carcinoma

Carcinoma, Transitional Cell

Urinary Bladder Neoplasms, Neoplasm Metastasis

Extensive Stage Lung Small Cell Carcinoma

Locally Advanced Cervical Cancer

Pancreatic Neoplasms

Uterine Cervical Neoplasms

Endometrial Neoplasms

Small Cell Lung Carcinoma

Clinical Trials

Therasphere® and Systemic Therapy for Patients With Hepatocellular Carcinoma That is High-risk

Clinical Trial of Atezolizumab With Paclitaxel, Trastuzumab, and Pertuzumab in Patients With Metastatic HER-2 Positive Breast Cancer

SATURN-STS: Phase II Study of Neoadjuvant Atezolizumab With Doxorubicin, Concurrent Atezolizumab With Pre-operative Radiation Therapy and Adjuvant Atezolizumab in Patients With High-risk Surgically Resectable Extremity and Truncal Soft Tissue Sarcoma

Liver-NET1

Safety and Efficacy of Cyclophosphamide, Sorafenib, Bevacizumab, and Atezolizumab in Pediatric Solid Tumor Patients

TAPUR

AtezoCab

GFPC 06-2018

Study of Abiraterone Acetate or Enzalutamide, Atezolizumab, GnRH Analog and Radiation Therapy in Men With Newly Diagnosed Hormone-sensitive Prostate Cancer

BARBICAN

Comparing Impact of Treatment Before or After Surgery in Patients With Stage II-IIIB Resectable Non-small Cell Lung Cancer

Neoadjuvant PD-1 Plus TIGIT Blockade in Patients With Cisplatin-Ineligible Operable High-Risk Urothelial Carcinoma

Phase 2 Trial of Neoadjuvant and Adjuvant Tiragolumab Plus Atezolizumab in Patients With Newly Diagnosed PD-L1 CPS Positive Resectable Stage 3-4 Oral Cavity Squamous Cell Carcinoma (OCSCC).

DARWINII

Atezolizumab + Sacituzumab Govitecan to Prevent Recurrence in TNBC (ASPRIA)

Testing Immunotherapy With or Without Stereotactic Body Radiation Therapy in Patients With Advanced Liver Cancer, HELIO-RT Trial

Plinabulin in Combination With Radiation/Immunotherapy in Patients With Select Advanced Cancers After Progression on PD-1 or PD-L1 Targeted Antibodies

Atezolizumab + Pertuzumab + Trastuzumab In CNS Mets In BC

Perioperative Immunotherapy for NSCLC (ECTOP-1030)

ATHENA

ATEZOGIST

COTESARC

Proton Beam Radiotherapy Followed by Tecentriq and Avastin for Primary Liver Cancer With Vp2-4 Portal Vein Invasion

Study of Sacituzumab Govitecan With Atezolizumab/Durvalumab as Maintenance Therapy for Extensive-Stage Small Cell Lung Cancer

Low-Dose Bevacizumab and Atezolizumab Combined With TACE-HAIC in Unresectable Hepatocellular Carcinoma

DSP-0390 in Combination With Atezolizumab for Small Cell Lung Cancer

Atezolizumab + Stereotactic Radiation in Triple-negative Breast Cancer and Brain Metastasis

BEATcc

A Phase II Study of Atezolizumab in Combination With Bevacizumab, Carboplatin or Cisplatin, and Pemetrexed for EGFR-mutant Metastatic Non-small Cell Lung Cancer Patients After Failure of EGFR Tyrosine Kinase Inhibitors.

AMBITION

MOAB

Modified Immune Cells (Autologous Dendritic Cells) and a Vaccine (Prevnar) Combined With Immune Checkpoint Inhibition After High-Dose External Beam Radiation Therapy in Treating Patients With Unresectable Liver Cancer

Evaluating Safety, Tolerability, and Preliminary Efficacy of YSCH-01 Monotherapy and in Combination With Atezolizumab for Recurrent Glioblastoma

Atezolizumab and Cabozantinib for the Treatment of Adolescents and Young Adults With Recurrent or Metastatic Osteosarcoma, TACOS Study

VITAS: Atezolizumab in Combination With Chemotherapy for Pediatric Relapsed/Refractory Solid Tumors

Bevacizumab and Atezolizumab With or Without Cobimetinib in Treating Patients With Untreated Melanoma Brain Metastases

LCNEC-ALPINE

Phase I/Ib Trial of TIraGolumab, AtEzolizumab, and RadScopal Radiation in Patients With Advanced Solid Malignancies (TIGER)

ACHILES

EndoBARR

Atezolizumab Plus Bevacizumab With HCC and HBV Infection

Temozolomide and Atezolizumab for Subsequent Line for the Treatment of Metastatic or Recurrent Small Cell Lung Cancer

A Study of Two Dosing Schedules of Atezolizumab in Combination With Gemcitabine and Cisplatin as First-Line Treatment for Metastatic Bladder Cancer

TOMBOLA

LB-100, Carboplatin, Etoposide, and Atezolizumab for the Treatment of Untreated Extensive-Stage Small Cell Lung Cancer

ATEZOLACC

Atezolizumab + Cabozantinib in Patients w/ Metastatic, Refractory Pancreatic Cancer

SBRT and Atezolizumab in the Management of Recurrent, Persistent, or Metastatic Cervical Cancer

EndoMAP

A Study of Valemetostat in Combination With Atezolizumab in People With Lung Cancer